TALPHERA, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
TALPHERA, INC. (TLPH) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $30.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-23
- TALPHERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $30.50M, a 951.72% increase from fiscal 2024.
- TALPHERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.90M, a 31.82% increase from fiscal 2023.
- TALPHERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $2.20M, a 83.70% decline from fiscal 2022.
- TALPHERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $13.50M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $30.50M 10-K · filed 2026-03-23 |
| 2024-12-31 | $2.90M 10-K · filed 2026-03-23 |
| 2023-12-31 | $2.20M 10-K · filed 2025-03-31 |
| 2022-12-31 | $13.50M 10-K · filed 2024-03-06 |
| 2021-12-31 | $6.40M 8-K · filed 2023-08-01 |
| 2020-12-31 | $11.40M 10-K · filed 2022-03-10 |
| 2019-12-31 | $12.90M 10-K · filed 2021-03-15 |
| 2018-12-31 | $9.90M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |